![]() Professor José Manuel Barroso, Chair of the Gavi Board: “Gavi’s record as an innovator and a disrupter in global health has been confirmed today.”.The Board also reconfirmed the essential role that Gavi plays in pandemic preparedness, prevention and response – discussing the progress made on the African Vaccine Manufacturing Accelerator, a financial instrument which aims to support sustainable vaccine manufacturing in Africa, as well as approving pilot investments for investigational candidate vaccines against Marburg and Ebola Sudan if needed for outbreak response, with discussion and potential approval of a broader programme in December 2023.Gavi’s Board approved new investments in six-in-one (hexavalent) vaccine and approved a long list of potential new vaccines for consideration for inclusion in future Gavi programmes at its Board Meeting, which concluded today.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |